Another unreasonable suppression! The U.S. House of Representatives has passed the Biosecurity Act, and wuxi apptec and wuxi bio have quickly responded.
①The U.S. House of Representatives passed the draft of the Biosecurity Act (H.R.8333) with 306 votes in favor and 81 votes against. ②Wuxi Apptec, Wuxi Bio, and other companies strongly opposed it. ③This bill still needs to be voted on by the Senate and the versions passed by both houses need to be reconciled before it can be submitted to the U.S. President for signing into law.
Sanbo Brain H1 net profit increased by more than 50% year-on-year, industry attention on expansion phase performance sustainability | Interpretations
①In the first half of this year, Sanbo Neurology achieved double growth in operating profit, mainly due to the expansion of the business scale and the increase in net income from acquiring companies; ② Sanbo Neurology is building two hospitals and plans to focus on the future expansion in the cni yangtze index and cni zhujiang index regions; ③ The industry is concerned about the sustainability of its expansion, the construction capabilities of the diagnostic and treatment team, and the relatively scarce professional talents in neurology.
AH trends diverge, Hang Seng Index up 0.6%, CNOOC up 4%, national bond futures slightly rebound.
Rare earth permanent magnets concept stocks pull back, photovoltaic and lithography themes also weaken. Hong Kong's real estate, banks, and oil & gas stocks are strong, CNOOC up 4%, Agricultural Bank of China and China Merchants Bank rise more than 2%. After experiencing a sharp drop yesterday, national bond futures rebounded in early trading, with 10-year and 30-year national bond futures contracts rising nearly 0.1% in early trading.
Hangzhou Tigermed Consulting Reports FY Results
2024 Financial Report | BGI's profit fell by more than 80%, making it difficult to find the next outlet
The era of gold everywhere is over
Pharmacovigilance disintegrates CXO, what is the market concerned about?
It was only in December that the full-year forecast was lowered. What kind of medicine does Yakumin Biotech sell in gourds?